CLOPIXOL ACUPHASE 50 MG
ZUCLOPENTHIXOL ACETATE : 50 MG · DIN 02230405 · LUNDBECK CANADA INC
Health Canada status: MARKETED
What is CLOPIXOL ACUPHASE?
CLOPIXOL ACUPHASE 50 MG contains ZUCLOPENTHIXOL ACETATE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02230405, held by LUNDBECK CANADA INC, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 02-May-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CLOPIXOL ACUPHASE used for?
CLOPIXOL (zuclopenthixol hydrochloride), CLOPIXOL ACUPHASE (zuclopenthixol acetate injection) and CLOPIXOL DEPOT (zuclopenthixol decanoate injection) are indicated for the management of the manifestations of schizophrenia. CLOPIXOL may be used during initial treatment and for maintenance treatment. CLOPIXOL ACUPHASE is intended for the initial treatment of acute psychotic episodes or exacerbation of psychosis associated with schizophrenia. CLOPIXOL DEPOT is intended for maintenance treatment.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02230405 |
|---|---|
| Brand name | CLOPIXOL ACUPHASE |
| Generic / active ingredient | ZUCLOPENTHIXOL ACETATE : 50 MG |
| Manufacturer | LUNDBECK CANADA INC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N05AF05 ZUCLOPENTHIXOL |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-May-1997 |
| Original market date | 1997-08-06 00:00:00 |
How is it stored and handled?
null
How is it supplied?
CLOPIXOL: 10 mg tablets: Supplied in bottles of 100 tablets. 25 mg tablets: Supplied in bottles of 100 tablets. CLOPIXOL ACUPHASE: Supplied in colourless glass ampoules of 1 mL and 2 mL, in packages of 5 ampoules. CLOPIXOL DEPOT: Supplied in clear glass ampoules of 1 mL in packages of 10 ampoules.
What can be used instead?
Other Canadian products sharing ATC code N05AF05 ZUCLOPENTHIXOL. 4 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLOPIXOL | 10 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02230402 |
| CLOPIXOL | 25 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02230403 |
| CLOPIXOL DEPOT | 200 MG | SOLUTION | LUNDBECK CANADA INC | MARKETED | DIN 02230406 |
| CLOPIXOL - TAB 10MG | 10 MG | TABLET | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162903 |
| CLOPIXOL - TAB 25MG | 25 MG | TABLET | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162911 |
| CLOPIXOL - TAB 40MG | 40 MG | TABLET | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162938 |
| CLOPIXOL ACUPHASE - LIQ IM 50MG/ML | 50 MG | LIQUID | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162946 |
| CLOPIXOL DEPOT - LIQ IM 200MG/ML | 200 MG | LIQUID | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162954 |
| CLOPIXOL DEPOT - LIQ IM 500MG/ML | 500 MG | LIQUID | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02162962 |
| CLOPIXOL DEPOT 500MG/ML | 500 MG | LIQUID | LUNDBECK CANADA INC | APPROVED | DIN 02230407 |
Who else supplies ZUCLOPENTHIXOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ZUCLOPENTHIXOL appears in 40 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.